Trial Summary
What is the purpose of this trial?The primary goals of this study are to determine the contribution of dietary oxalate absorption, renal oxalate handling, and endogenous oxalate synthesis to urinary oxalate excretion in normal Body Mass Index (BMI) and obese calcium oxalate kidney stone formers.
Eligibility Criteria
This trial is for adults with normal (BMI ≥ 18.5 to < 25) or obese (BMI ≥ 30 to ≤ 45) who form calcium oxalate kidney stones, can consent, and follow a controlled diet without vigorous exercise. Excluded are those with diabetes, abnormal blood tests, certain kidney diseases, gastrointestinal disorders affecting oxalate transport, recent cancer treatment, pregnancy or breastfeeding women not using birth control.Inclusion Criteria
No food allergies or intolerance to any of the food in study menus
Willingness to not undertake vigorous exercise during the controlled dietary study
I am willing to stop my kidney stone prevention meds for the study duration.
+9 more
Exclusion Criteria
I have been diagnosed with primary hyperparathyroidism.
I have high oxalate levels in my urine due to intestinal issues.
Your fasting blood test shows abnormal results for your body's chemical levels.
+28 more
Participant Groups
The study investigates how obesity affects the body's processing of oxalate in people prone to calcium oxalate kidney stones. Participants will follow a controlled diet and ingest Carbon-13 Oxalate and Sucralose to track their metabolism and urinary excretion patterns.
1Treatment groups
Experimental Treatment
Group I: Controlled Dietary StudyExperimental Treatment2 Interventions
Participants will consume the controlled diet for five days. After one day on the diet, subjects will provide three 24-hour urine collections. On the last dayof the diet, subjects will come in a fasted state to ingest a small amount of carbon-13 oxalate and sucralose, with hourly urine collections and blood samples being taken before and after the ingestion.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Alabama at BirminghamBirmingham, AL
University of Texas Southwestern Medical CenterDallas, TX
Loading ...
Who Is Running the Clinical Trial?
University of Alabama at BirminghamLead Sponsor